CervoMed Inc.
CRVO
$2.73
-$0.20-6.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 331.30K | 2.09M | 4.01M | 6.16M | 7.78M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 331.30K | 2.09M | 4.01M | 6.16M | 7.78M |
| Cost of Revenue | 17.14M | 17.13M | 16.83M | 18.09M | 17.17M |
| Gross Profit | -16.81M | -15.04M | -12.82M | -11.93M | -9.39M |
| SG&A Expenses | 10.17M | 11.08M | 10.48M | 10.29M | 10.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.50M | 33.19M | 32.30M | 33.36M | 32.33M |
| Operating Income | -31.16M | -31.10M | -28.29M | -27.20M | -24.56M |
| Income Before Tax | -30.35M | -30.04M | -26.97M | -25.58M | -22.61M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -30.35 | -30.04 | -26.97 | -25.58 | -22.61 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.35M | -30.04M | -26.97M | -25.58M | -22.61M |
| EBIT | -31.16M | -31.10M | -28.29M | -27.20M | -24.56M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -3.21 | -3.27 | -2.97 | -2.87 | -2.58 |
| Normalized Basic EPS | -2.01 | -2.04 | -1.86 | -1.79 | -1.61 |
| EPS Diluted | -3.21 | -3.27 | -2.97 | -2.87 | -2.58 |
| Normalized Diluted EPS | -2.01 | -2.04 | -1.86 | -1.79 | -1.61 |
| Average Basic Shares Outstanding | 38.01M | 36.72M | 36.16M | 35.61M | 35.06M |
| Average Diluted Shares Outstanding | 38.01M | 36.72M | 36.16M | 35.61M | 35.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |